Cancer Research Technology
Log in Register
Menu

Anti-HPV16E2 [TVG 271]

Invented at University of Cambridge

Info

Catalogue Number 151168
Applications ELISA WB
Antigen/Gene or Protein Targets Human Papilloma virus-16 early protein 2 (HPV16 E2)
Reactivity Human papilloma virus
Relevance The human papilloma virus (HPV) family of DNA tumor viruses includes HPV-16 and HPV-18, which are associated with a large proportion of cervical cancer cases. E1 and E2 are proteins involved in the regulation of viral DNA replication. TVG 271 is useful for detection of protein in cervical lesions. TVG 271 completely inhibits E2 binding to E1.
Host Mouse
Immunogen Maltose binding protein MBP-E2 (generated from an expression vector in which the E2 ORF was cloned in frame with malE)
Subclass IgG1
Myeloma Used P3/NS1/1-Ag4.1
Recommended Growing Conditions DMEM + 5% FCS
Strain Balb/c
Research Area Cancer, Virology

References

There are 3 reference entries for this reagent.

View All References

References: 3 entries

A deletion in the gene encoding the CD45 antigen in a patient with SCID.

Europe PMC ID: 11145714

Hibma et al. 1995. Eur J Biochem. 229(2):517-25. PMID: 7744075.

ELISA WB

The interaction between human papillomavirus type 16 E1 and E2 proteins is blocked by an antibody to the N-terminal region of E2.

Europe PMC ID: 7744075


Add a reference

References: 3 entries

A deletion in the gene encoding the CD45 antigen in a patient with SCID.

Hibma et al. 1995. Eur J Biochem. 229(2):517-25. PMID: 7744075.

ELISA WB

The interaction between human papillomavirus type 16 E1 and E2 proteins is blocked by an antibody to the N-terminal region of E2.


Add a reference

Inventor Information

No inventors are currently linked to this reagent.

Add an inventor